Pneumococcal vaccination of the elderly: Do we need another trial?

被引:4
作者
Hak, E
Grobbee, DE
van Essen, GA
Buskens, E
Verheij, TJM
机构
关键词
D O I
10.1001/archinte.160.11.1698-a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1698 / 1699
页数:2
相关论文
共 5 条
[1]  
Hak E, 1997, BRIT J GEN PRACT, V47, P363
[2]   Is immunising all patients with chronic lung disease in the community against influenza cost effective? Evidence from a general practice based clinical prospective cohort study in Utrecht, the Netherlands [J].
Hak, E ;
van Essen, GA ;
Buskens, E ;
Stalman, W ;
de Melker, RA .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1998, 52 (02) :120-125
[3]   Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older [J].
Honkanen, PO ;
Keistinen, T ;
Miettinen, L ;
Herva, E ;
Sankilampi, U ;
Läärä, E ;
Leinonen, M ;
Kivelä, SL ;
Mäkela, PH .
VACCINE, 1999, 17 (20-21) :2493-2500
[4]   The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease [J].
Nichol, KL ;
Baken, L ;
Wuorenma, J ;
Nelson, A .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (20) :2437-2442
[5]   Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people [J].
Örtqvist, Å ;
Hedlund, J ;
Burman, LÅ ;
Elbel, N ;
Höfer, M ;
Leinonen, M ;
Lindblad, I ;
Sundelöf, B ;
Kalin, M .
LANCET, 1998, 351 (9100) :399-403